FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a new method for the chemical synthesis of asymmetrically or symmetrically substituted β-(1→6)-bound glucosamine disaccharide of formula 
(1), as well as to a method for purifying it. The invention declared the intermediate compounds referred to the given method.
EFFECT: invention refers to a pharmaceutical composition comprising the mentioned compounds, and to the use of the compounds in treating the disorders affected by immune system activity modulation, including the inhibition or activation of the immune system, such as a disorder selected from immune disorders and/or cancer.
26 cl, 8 ex, 26 dwg
